MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-18-0000717
Oncostar Pharma Private Limited
Oncostar Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹56.54 Lakh
▲ 9% YoY
Net profit · FY 2025
₹40,983
Net margin 0.7%
EBITDA · FY 2025
₹1.71 Lakh
EBITDA margin 3%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Oncostar Pharma Private Limited
Data last updated:
Oncostar Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2014PTC254996. Its GSTIN is 27AABCO9942P1ZN (Maharashtra).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Trupti Jayant Gosalia and Santosh Mohanlal Bhansali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lower Level – 6 Ll – 6 Hi Life P.M. Street Santacruz (West), Mumbai, Maharashtra, India – 400054.
As per the financials filed for FY 2025, the company reported a revenue of ₹56.54 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹40,983 (net margin 0.7%) and EBITDA of ₹1.71 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
Oncostar Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0000717). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100MH2014PTC254996
Registration Number 254996
Incorporation Date 25 March 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-18-0000717
Recognitions & Rankings of Oncostar Pharma
Contact details
Oncostar Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressLower Level – 6 Ll – 6 Hi Life P.M. Street Santacruz (West), Mumbai, Maharashtra, India – 400054
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Oncostar Pharma Private Limited, buy the company report.
Comprehensive company report
Oncostar Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Oncostar Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Oncostar Pharma Private Limited, buy the company report.
Financials of Oncostar Pharma Private Limited
FY 2025 filings availableOncostar Pharma Private Limited reported revenue of ₹56.54 Lakh (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹56.54 Lakh ▲ 9%
Net profit · FY 2025
₹40,983 margin 0.7%
EBITDA · FY 2025
₹1.71 Lakh margin 3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 6%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 32%
Revenue rose 9% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.71 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹40,983 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Oncostar Pharma Private Limited, buy the company report.
Board of directors of Oncostar Pharma Private Limited
Oncostar Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Trupti Jayant Gosalia Also directs: Nuris Pharma Private Limited | Director | 25 Mar 2014 | 12 Years 7 Months | Current |
| Santosh Mohanlal Bhansali | Director | 05 Oct 2024 | 2 Years 1 Months | Current |
Auditor
Oncostar Pharma Private Limited is audited by M H DALAL & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M H DALAL & ASSOCIATES | FY 2020 | 112449W |
Shareholding
The shareholding of Oncostar Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Oncostar Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oncostar Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Oncostar Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Oncostar Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCO9942P1ZN | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Oncostar Pharma Private Limited, buy the company report.
Recent activity
Oncostar Pharma Private Limited has 6 board changes on record since 2014: 2 appointments and 4 cessations. The latest: Santosh Mohanlal Bhansali ceased to be Additional Director on 29 Sep 2025.
AGM
Oncostar Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Santosh Mohanlal Bhansali ceased to be Additional Director.
Filing
Oncostar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Santosh Mohanlal Bhansali was appointed as Director.
Ceased
Babita Sanjay Bhandari ceased to be Additional Director.
Ceased
Deepak Kumar ceased to be Director.
Ceased
Smita Tarun Modi ceased to be Additional Director.
Appointed
Trupti Jayant Gosalia was appointed as Director.
Incorporation
25 Mar 2014
Oncostar Pharma Private Limited was registered on 25 Mar 2014 with Roc Mumbai I & aged 12 years 7 months as per MCA records.
Frequently asked questions
Oncostar Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 March 2014 (12+ years old) and is registered under CIN U24100MH2014PTC254996.
Oncostar Pharma has 2 current directors:
- Trupti Jayant Gosalia - Director
- Santosh Mohanlal Bhansali - Director
The latest financial statements of Oncostar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Oncostar Pharma is 27AABCO9942P1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Oncostar Pharma is U24100MH2014PTC254996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oncostar Pharma was incorporated on 25 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Santosh Mohanlal Bhansali ceased to be Additional Director on 29 Sep 2025. Santosh Mohanlal Bhansali was appointed as Director on 05 Oct 2024. Babita Sanjay Bhandari ceased to be Additional Director on 29 Sep 2024. Oncostar Pharma has 6 board changes on record in total.
Yes, Oncostar Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-18-0000717).
The registered office of Oncostar Pharma is at Lower Level – 6 Ll – 6 Hi Life P.M. Street Santacruz West, Mumbai, Maharashtra, India – 400054.
Oncostar Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages